WO2011146032A3 - Effervescent formulations - Google Patents

Effervescent formulations Download PDF

Info

Publication number
WO2011146032A3
WO2011146032A3 PCT/TR2011/000112 TR2011000112W WO2011146032A3 WO 2011146032 A3 WO2011146032 A3 WO 2011146032A3 TR 2011000112 W TR2011000112 W TR 2011000112W WO 2011146032 A3 WO2011146032 A3 WO 2011146032A3
Authority
WO
WIPO (PCT)
Prior art keywords
effervescent formulations
formulations
effervescent
levocetirizine
flavor
Prior art date
Application number
PCT/TR2011/000112
Other languages
French (fr)
Other versions
WO2011146032A2 (en
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Priority to EP11740739A priority Critical patent/EP2571484A2/en
Publication of WO2011146032A2 publication Critical patent/WO2011146032A2/en
Publication of WO2011146032A3 publication Critical patent/WO2011146032A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to stable levocetirizine effervescent formulations flavor and taste of which is improved, and method for preparation of said formulations.
PCT/TR2011/000112 2010-05-18 2011-05-16 Effervescent formulations WO2011146032A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11740739A EP2571484A2 (en) 2010-05-18 2011-05-16 Effervescent formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201003940 2010-05-18
TR2010/03940 2010-05-18

Publications (2)

Publication Number Publication Date
WO2011146032A2 WO2011146032A2 (en) 2011-11-24
WO2011146032A3 true WO2011146032A3 (en) 2012-03-08

Family

ID=44484008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000112 WO2011146032A2 (en) 2010-05-18 2011-05-16 Effervescent formulations

Country Status (2)

Country Link
EP (1) EP2571484A2 (en)
WO (1) WO2011146032A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013058721A1 (en) * 2011-10-13 2013-04-25 Mahmut Bilgic Pharmaceutical granules and production method
WO2016140630A1 (en) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine
JP2023549381A (en) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． Orodispersible powder compositions containing antihistamine active compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245353B1 (en) * 1998-03-31 2001-06-12 Asta Medica Ag Solid, rapidly disintegrating cetirizine formulations
WO2003059328A1 (en) * 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
US20060127479A1 (en) * 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
WO2010028101A1 (en) * 2008-09-05 2010-03-11 Mcneil-Ppc, Inc. Method for making cetirizine tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (en) 1981-02-06 1988-08-08 Ucb Sa Process for the preparation of therapeutically active 2- [4- (diphenylmethyl) -1-piperazinyl] -acetic acid or its amide
CA2212829A1 (en) 1995-02-21 1996-08-29 Jiro Takeo Glutamic acid receptor agonist

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245353B1 (en) * 1998-03-31 2001-06-12 Asta Medica Ag Solid, rapidly disintegrating cetirizine formulations
WO2003059328A1 (en) * 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
US20060127479A1 (en) * 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
WO2010028101A1 (en) * 2008-09-05 2010-03-11 Mcneil-Ppc, Inc. Method for making cetirizine tablets

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEVADA SINGH-FRANCO ET AL: "Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children", CLINICAL THERAPEUTICS, vol. 31, no. 8, 1 August 2009 (2009-08-01), pages 1664 - 1687, XP055005754, ISSN: 0149-2918, DOI: 10.1016/j.clinthera.2009.08.015 *

Also Published As

Publication number Publication date
WO2011146032A2 (en) 2011-11-24
EP2571484A2 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
WO2011093832A3 (en) Stable efervescent formulations comprising cefaclor
WO2011079167A3 (en) Oral care compositions
ZA201208490B (en) Compounds,compositions, and methods for reducing or eliminating bitter taste
ZA201208488B (en) Compounds,compositions,and methods for reducing or eliminating bitter taste
WO2012174487A3 (en) Bromodomain inhibitors and uses thereof
WO2012151512A3 (en) Bromodomain inhibitors and uses thereof
WO2012075383A3 (en) Bromodomain inhibitors and uses thereof
WO2012146584A3 (en) Specific vanillyl lignans and use thereof as taste improvers
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2011019822A3 (en) Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
MX2012013024A (en) Sweetener compositions with reduced bitter off taste and methods of preparing.
WO2012021715A3 (en) Stable formulations of linaclotide
WO2013032189A3 (en) Fermented vegetable oil and composition including same
WO2011122869A3 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
WO2012016683A3 (en) Oral dosage form of pregabalin
HK1201177A1 (en) Compounds, compositions, and methods for reducing or eliminating bitter taste
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
BR112013015320A2 (en) taste modulation by bioprocessing using cream flavor forming bacterial strains
WO2010079013A3 (en) Umami active fraction, method to prepare the same, method of enhancing umami taste and method of preparing a food product
WO2012088222A3 (en) Methods and compositions for producing active vitamin k-dependent proteins
WO2012078004A3 (en) Composition comprising fermented tea extracts for reducing lipid level
WO2012030764A3 (en) Human milk preparation
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2011146032A3 (en) Effervescent formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11740739

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2011740739

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011740739

Country of ref document: EP